Literature DB >> 28660570

Isolation of Lipid Raft Proteins from CD133+ Cancer Stem Cells.

Vineet K Gupta1, Sulagna Banerjee2.   

Abstract

Pancreatic cancer cells expressing the surface markers CD133 have been widely reported as cancer stem cells and mainly responsible for tumor recurrence and chemoresistance in pancreatic cancer. In spite of its role as a stem cell marker in pancreatic cancer, its function remains elusive. CD133 (also known as prominin-1) is a pentaspan glycoprotein predominantly localized in lipid rafts, specialized membrane microdomains enriched in crucial signaling proteins. Coexistence of CD133 with these signaling proteins can modulate various signaling pathways that might be responsible for aggressive phenotype of CD133+ cells. This chapter describes a detailed protocol to isolate lipid rafts from CD133+ tumor initiating cells. Purified lipid rafts can be investigated further for protein or lipid composition by mass spectrometry that can shed some light on functional role of CD133 protein in these cancer stem cells.

Entities:  

Keywords:  CD133; Cancer stem cells; Lipid rafts; Pancreatic cancer; Tumor Initiating Cells

Mesh:

Substances:

Year:  2017        PMID: 28660570      PMCID: PMC7958413          DOI: 10.1007/978-1-4939-6996-8_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

Review 1.  Regulation of Par6 by extracellular signals.

Authors:  Rohit Bose; Jeffrey L Wrana
Journal:  Curr Opin Cell Biol       Date:  2006-02-20       Impact factor: 8.382

2.  CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.

Authors:  Sulagna Banerjee; Alice Nomura; Veena Sangwan; Rohit Chugh; Vikas Dudeja; Selwyn M Vickers; Ashok Saluja
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

3.  Nodal/Activin signaling: a novel target for pancreatic cancer stem cell therapy.

Authors:  Timothy R Donahue; David W Dawson
Journal:  Cell Stem Cell       Date:  2011-11-04       Impact factor: 24.633

4.  A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration.

Authors:  M A Maw; D Corbeil; J Koch; A Hellwig; J C Wilson-Wheeler; R J Bridges; G Kumaramanickavel; S John; D Nancarrow; K Röper; A Weigmann; W B Huttner; M J Denton
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

5.  Prominin-1-containing membrane vesicles: origins, formation, and utility.

Authors:  Anne-Marie Marzesco
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 6.  Epithelial organization, cell polarity and tumorigenesis.

Authors:  Luke Martin McCaffrey; Ian G Macara
Journal:  Trends Cell Biol       Date:  2011-07-21       Impact factor: 20.808

Review 7.  The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation.

Authors:  Denis Corbeil; Anne-Marie Marzesco; Michaela Wilsch-Bräuninger; Wieland B Huttner
Journal:  FEBS Lett       Date:  2010-02-02       Impact factor: 4.124

8.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 9.  Pancreatic cancer stem cells and relevance to cancer treatments.

Authors:  Filip Bednar; Diane M Simeone
Journal:  J Cell Biochem       Date:  2009-05-01       Impact factor: 4.429

10.  Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions.

Authors:  J D Lathia; M Hitomi; J Gallagher; S P Gadani; J Adkins; A Vasanji; L Liu; C E Eyler; J M Heddleston; Q Wu; S Minhas; A Soeda; D J Hoeppner; R Ravin; R D G McKay; R E McLendon; D Corbeil; A Chenn; A B Hjelmeland; D M Park; J N Rich
Journal:  Cell Death Dis       Date:  2011-09-01       Impact factor: 8.469

View more
  6 in total

1.  Prominin-1/CD133: Lipid Raft Association, Detergent Resistance, and Immunodetection.

Authors:  Jana Karbanová; Aurelio Lorico; Martin Bornhäuser; Denis Corbeil; Christine A Fargeas
Journal:  Stem Cells Transl Med       Date:  2017-12-22       Impact factor: 6.940

Review 2.  Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer.

Authors:  Michela Codini; Mercedes Garcia-Gil; Elisabetta Albi
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

Review 3.  Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance.

Authors:  Bao Q Lam; Rashmi Srivastava; Jason Morvant; Sharmila Shankar; Rakesh K Srivastava
Journal:  Cells       Date:  2021-11-08       Impact factor: 6.600

Review 4.  The lipid rafts in cancer stem cell: a target to eradicate cancer.

Authors:  Shuo Zhang; Neng Zhu; Hong Fang Li; Jia Gu; Chan Juan Zhang; Duan Fang Liao; Li Qin
Journal:  Stem Cell Res Ther       Date:  2022-08-30       Impact factor: 8.079

Review 5.  Rafting Down the Metastatic Cascade: The Role of Lipid Rafts in Cancer Metastasis, Cell Death, and Clinical Outcomes.

Authors:  Joshua D Greenlee; Tejas Subramanian; Kevin Liu; Michael R King
Journal:  Cancer Res       Date:  2020-09-30       Impact factor: 13.312

Review 6.  Cancer stem cell metabolism: target for cancer therapy.

Authors:  Young Chan Chae; Jae Ho Kim
Journal:  BMB Rep       Date:  2018-07       Impact factor: 4.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.